Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations. The disease is characterized ...
Mar 20, 2026
0
2620
Rheumatic and musculoskeletal disorders (RMDs) like arthritis are having a significant impact on how long people across Europe can remain healthy while working, according to a new study. A research team from Keele University ...
Mar 17, 2026
0
5
Arthritis is often associated with older age, but it also affects children. One of the most common forms is juvenile idiopathic arthritis (JIA), an inflammatory condition that causes persistent joint swelling and pain.
Mar 17, 2026
0
4
Research at Clarkson University is helping people with hypermobile Ehlers-Danlos syndrome (hEDS) move with less pain and more confidence. The study, published in the Journal of Multidisciplinary Healthcare, looked at whether ...
Mar 17, 2026
0
6
Joint pain is often dismissed as aging, overuse or a minor injury. But for some people it is the first sign of inflammatory arthritis, a group of immune-driven conditions that can damage joints and other organs if not treated ...
Mar 14, 2026
0
8
A new study has found that a prebiotic fiber supplement reduced pain, improved grip strength, and lowered pain sensitivity in people with knee osteoarthritis (OA)—with far fewer dropouts than a digital physiotherapy program. ...
Mar 12, 2026
0
205
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).
Mar 12, 2026
0
6
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
Mar 11, 2026
0
6
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...
Mar 10, 2026
0
7
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of ...
Mar 2, 2026
0
9
